Penza, 10 January 2012. PenzaNews. The Penza pharmaceutical enterprise of Open Joint-Stock Company “Biosintez” is included in the list of the open joint-stock companies, actions being in the federal property are planned to privatization in 2011-2013. The corresponding order has been signed by the chairman of the government of the Russian Federation Vladimir Putin on December, 26th, 2011.

© PenzaNewsBuy the photo

According to the document, to privatization 27 341 action which is now in the federal property that makes 9.55 % of actions of the enterprise is planned.

The Penza plant of medical preparations was established in 1959. Production of antibiotic substances by fermentation was chosen as a main direction of its activity, and antibiotic biomycin (chlortetracycline) and vitamin B12 were the first products.

Later other antibiotic substances were included into product list: oleandomycin, tetracycline, nystatin, heliomycin (Gold medal of Exhibition of Achievements of National Economy in 1970), fusidic acid and sodium fusidate, levorin (candicidin) (Gold medal of Plovdiv Exhibition in 1977), benzylpenicillin potassium, mycoheptin, as well as cardiovascular riboxin (inosin).

Besides the substances, as early as in 1961 the Plant began to produce the formulated preparations, tablets, in 1971 manufactures of infusions and filling of powders for injection were put into operation.

Also production of endocrine preparations was organized, in 1986 – insulin, in 1989 – heparin. In 1987 the Plant had been reorganized in the Combine of medical preparations in connection with multifarious character of manufacture, and in November 1992 it had been reorganized in Open Joint-Stock Company “Biosintez”.